Metabolic patterns and clinical response to levedopa therapy in Parkinson's disease.
D006916:5-Hydroxytryptophan / Q000652:urine; D000368:Aged; D002394:Catechol O-Methyltransferase / Q000378:metabolism; D004032:Diet; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use* / Q000652:urine; D004837:Epinephrine / Q000652:urine; D006719:Homovanillic Acid / Q000652:urine; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine; D008297:Male; D009460:Neurologic Examination; D010300:Parkinson Disease / Q000188:drug therapy*; D010648:Phenylacetates / Q000652:urine; D011569:Psychiatric Status Rating Scales; D012701:Serotonin / Q000652:urine; D013997:Time Factors; D014282:Trihexyphenidyl / Q000627:therapeutic use
D010648:Phenylacetates; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D004295:Dihydroxyphenylalanine; D014282:Trihexyphenidyl; D006916:5-Hydroxytryptophan; D002394:Catechol O-Methyltransferase; D006719:Homovanillic Acid; D004837:Epinephrine